Pàgina inicial > Resultats de la cerca: Ciriaco, 0000-0002-1151-554X
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:

No s'ha trobat cap coincidència exacta per Ciriaco, 0000-0002-1151-554X, però canviant-lo per Ciriaco 0000 0002 1151 554X...
Resultats globals: 3 registres trobats en 0.15 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
12 p, 815.7 KB Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response / Ciriaco, Nikaoly (Hospital del Mar (Barcelona, Catalunya)) ; Zamora, Esther (Hospital Universitari Vall d'Hebron) ; Escrivá-de-Romaní, Santiago (Hospital Universitari Vall d'Hebron) ; Miranda Gómez, Ignacio (Hospital Universitari Vall d'Hebron) ; Jiménez Flores, José (Vall d'Hebron Institut d'Oncologia) ; Saura, Cristina (Hospital Universitari Vall d'Hebron) ; Sloane, Hillary ; Starus, Anna ; Fredebohm, Johannes ; Georgieva, Lucy ; Speight, Graham ; Jones, Frederick ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron) ; Espinosa-Bravo, Martín (Hospital Universitari Vall d'Hebron) ; Peg, Vicente (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Although the standard of care is to perform surgery of primary breast cancer (BC) after neoadjuvant chemotherapy (NAC), for certain patients achieving clinical complete response (cCR) and pathologic complete response (pCR), omission of surgical treatment may be an option. [...]
2022 - 10.1177/17588359221139601
Therapeutic Advances in Medical Oncology, Vol. 14 (november 2022)  
Registre complet - Creative Commons
2.
22 p, 8.7 MB pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation / Boix, Olga (Vall d'Hebron Institut d'Oncologia) ; Martínez, Marion (Vall d'Hebron Institut d'Oncologia) ; Vidal, Santiago (Universidade de Santiago de Compostela) ; Giménez-Alejandre, Marta (Vall d'Hebron Institut d'Oncologia) ; Palenzuela, Lluís (Vall d'Hebron Institut d'Oncologia) ; Lorenzo-Sanz, Laura (Institut d'Investigació Biomèdica de Bellvitge) ; Quevedo, Laura (Universidad de Cantabria) ; Moscoso, Olivier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Orera, Jorge (Max Delbrück Center for Molecular Medicine in the Helmholtz Association) ; Ximénez-Embún, Pilar (Centro Nacional de Investigaciones Oncológicas) ; Ciriaco, Nikaoly (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ; Stephan-Otto Attolini, Camille (Institute for Research in Biomedicine (IRB Barcelona)) ; Albà, M. Mar (Institució Catalana de Recerca i Estudis Avançats) ; Muñoz, Javier (Centro Nacional de Investigaciones Oncológicas) ; Tian, Tian V. (Vall d'Hebron Institut d'Oncologia) ; Varela, Ignacio (Universidad de Cantabria) ; Vivancos, Ana (Vall d'Hebron Institut d'Oncologia) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Muñoz, Purificación (Institut d'Investigació Biomèdica de Bellvitge) ; Rivas Vázquez, Carmen (Centro Nacional de Biotecnología (Madrid)) ; Abad, María (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
The human transcriptome contains thousands of small open reading frames (sORFs) that encode microproteins whose functions remain largely unexplored. Here, we show that TINCR lncRNA encodes pTINCR, an evolutionary conserved ubiquitin-like protein (UBL) expressed in many epithelia and upregulated upon differentiation and under cellular stress. [...]
2022 - 10.1038/s41467-022-34529-6
Nature communications, Vol. 13 (november 2022)  
Registre complet - Creative Commons
3.
30 p, 7.5 MB The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer / De Mattos-Arruda, Leticia (Vall d'Hebron Institut d'Oncologia) ; Sammut, Stephen-John (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Ross, Edith M. (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Bashford-Rogers, Rachael (Department of Medicine. University of Cambridge) ; Greenstein, Erez (Weizmann Institute of Science (Israel). Department of Immunology) ; Markus, Havell (Mayo Clinic Center for Individualized Medicine) ; Morganella, Sandro (Department of Medical Genetics. The Clinical School. University of Cambridge) ; Teng, Yvonne (Cancer Molecular Diagnosis Laboratory. NIHR Cambridge Biomedical Research Centre) ; Maruvka, Yosef (Massachusetts General Hospital (Boston)) ; Pereira, Bernard (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Rueda, Oscar M. (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Chin, Suet-Feung (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Contente-Cuomo, Tania (Mayo Clinic Center for Individualized Medicine) ; Mayor, Regina (Centro de Investigación Biomédica en Red de Cáncer) ; Arias, Alexandra (Vall d'Hebron Institut d'Oncologia) ; Ali, H. Raza (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Cope, Wei (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Tiezzi, Daniel (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Dariush, Aliakbar (Institute of Astronomy. University of Cambridge) ; Dias Amarante, Tauanne (Department of Medical Genetics. The Clinical School. University of Cambridge) ; Reshef, Dan (Weizmann Institute of Science (Israel). Department of Immunology) ; Ciriaco, Nikaoly (Hospital Universitari Vall d'Hebron) ; Martinez-Saez, Elena (Hospital Universitari Vall d'Hebron) ; Peg, Vicente (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cortés, Javier (Vall d'Hebron Institut d'Oncologia) ; Vassiliou, George (Wellcome Trust/MRC Cambridge Stem Cell Institute) ; Getz, Gad (Massachusetts General Hospital (Boston)) ; Nik-Zainal, Serena (Department of Medical Genetics. The Clinical School. University of Cambridge) ; Murtaza, Muhammed (Mayo Clinic Center for Individualized Medicine) ; Friedman, Nir (Weizmann Institute of Science (Israel). Department of Immunology) ; Markowetz, Florian (Department of Oncology and Cancer Research UK Cambridge Institute. Li Ka Shing Centre. University of Cambridge) ; Seoane Suárez, Joan (Vall d'Hebron Institut d'Oncologia) ; Caldas, Carlos (Cancer Research UK Cambridge Cancer Centre (Regne Unit)) ; Universitat Autònoma de Barcelona
The detailed molecular characterization of lethal cancers is a prerequisite to understanding resistance to therapy and escape from cancer immunoediting. We performed extensive multi-platform profiling of multi-regional metastases in autopsies from 10 patients with therapy-resistant breast cancer. [...]
2019 - 10.1016/j.celrep.2019.04.098
Cell reports, Vol. 27 Núm. 9 (28 2019) , p. 2690-2708.e10  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem